We also found that tumor-specific variants were enriched in several molecular functions including nucleotide binding (GO: 0000166), which is not unexpected, as several nucleotide binding genes, such as GNB2L1, are found to be involved in cancers [31]. This evidence concerns the gene RACK1 and neoplasm.